Free Trial

MetLife (MET) Stock Price, News & Analysis

MetLife logo
$77.07 +0.51 (+0.66%)
As of 12:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MetLife Stock (NYSE:MET)

Key Stats

Today's Range
$76.71
$77.32
50-Day Range
$73.78
$81.02
52-Week Range
$65.21
$89.05
Volume
834,847 shs
Average Volume
3.42 million shs
Market Capitalization
$51.25 billion
P/E Ratio
13.06
Dividend Yield
2.95%
Price Target
$96.00
Consensus Rating
Moderate Buy

Company Overview

MetLife Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

MET MarketRank™: 

MetLife scored higher than 100% of companies evaluated by MarketBeat, and ranked 1st out of 936 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MetLife has received a consensus rating of Moderate Buy. The company's average rating score is 2.91, and is based on 10 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    MetLife has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about MetLife's stock forecast and price target.
  • Earnings Growth

    Earnings for MetLife are expected to grow by 9.53% in the coming year, from $9.65 to $10.57 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MetLife is 12.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.45.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MetLife is 12.98, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 19.54.

  • Price to Earnings Growth Ratio

    MetLife has a PEG Ratio of 0.66. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    MetLife has a P/B Ratio of 1.82. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about MetLife's valuation and earnings.
  • Percentage of Shares Shorted

    1.44% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently increased by 14.31%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MetLife pays a meaningful dividend of 3.01%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    MetLife has been increasing its dividend for 12 years.

  • Dividend Coverage

    The dividend payout ratio of MetLife is 38.47%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, MetLife will have a dividend payout ratio of 21.48% next year. This indicates that MetLife will be able to sustain or increase its dividend.

  • Read more about MetLife's dividend.
  • Percentage of Shares Shorted

    1.44% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently increased by 14.31%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MetLife has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 69 news articles for MetLife this week, compared to 37 articles on an average week.
  • Search Interest

    26 people have searched for MET on MarketBeat in the last 30 days. This is an increase of 37% compared to the previous 30 days.
  • MarketBeat Follows

    10 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MetLife insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.35% of the stock of MetLife is held by insiders.

  • Percentage Held by Institutions

    94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MetLife's insider trading history.
Receive MET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter.

MET Stock News Headlines

The Top 5 Analyst Questions From MetLife’s Q2 Earnings Call
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
See More Headlines

MET Stock Analysis - Frequently Asked Questions

MetLife's stock was trading at $81.88 at the start of the year. Since then, MET shares have decreased by 6.5% and is now trading at $76.5590.

MetLife, Inc. (NYSE:MET) issued its quarterly earnings data on Wednesday, August, 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts' consensus estimates of $2.32 by $0.30. The company's revenue for the quarter was down 2.7% compared to the same quarter last year.
Read the conference call transcript
.

MetLife's Board of Directors authorized a stock repurchase plan on Wednesday, April 30th 2025, which permits the company to buy back $3,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 5.9% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's board believes its stock is undervalued.

The following companies are subsidiaries of MetLife: Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and others.

MetLife's top institutional shareholders include Vanguard Group Inc. (8.52%), Geode Capital Management LLC (1.91%), Pzena Investment Management LLC (1.36%) and Bank of New York Mellon Corp (1.21%). Insiders that own company stock include Steven J Goulart, Ramy Tadros, Marlene Debel, Bill Pappas, Susan M Podlogar and Jeh C Johnson.
View institutional ownership trends
.

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Exxon Mobil (XOM), Salesforce (CRM) and Verizon Communications (VZ).

Company Calendar

Record date for 6/10 Dividend
5/06/2025
Ex-Dividend for 6/10 Dividend
5/06/2025
Dividend Payable
6/10/2025
Record date for 9/9 Dividend
8/05/2025
Ex-Dividend for 9/9 Dividend
8/05/2025
Last Earnings
8/06/2025
Today
8/13/2025
Dividend Payable
9/09/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
INS - MULTI LINE
Sub-Industry
Life & Health Insurance
Current Symbol
NYSE:MET
CIK
1099219
Employees
45,000
Year Founded
1868

Price Target and Rating

High Price Target
$103.00
Low Price Target
$91.00
Potential Upside/Downside
+25.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.91
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$5.90
Trailing P/E Ratio
12.98
Forward P/E Ratio
7.93
P/E Growth
0.66
Net Income
$4.43 billion
Net Margins
5.83%
Pretax Margin
7.82%
Return on Equity
19.88%
Return on Assets
0.82%

Debt

Debt-to-Equity Ratio
0.57
Current Ratio
0.16
Quick Ratio
0.16

Sales & Book Value

Annual Sales
$70.99 billion
Price / Sales
0.72
Cash Flow
$7.30 per share
Price / Cash Flow
10.49
Book Value
$41.99 per share
Price / Book
1.82

Miscellaneous

Outstanding Shares
665,030,000
Free Float
668,948,000
Market Cap
$50.91 billion
Optionable
Optionable
Beta
0.85

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:MET) was last updated on 8/13/2025 by MarketBeat.com Staff
From Our Partners